Skip to content
OpenCapital
Get started

Tevogen Bio Holdings, Inc. TVGN Q4 2024 Annual earnings

Reported April 2, 2025

EPS-$2.60Miss by $2.56
EPS estimate-$0.03

Next report

Aug 13, 2026 (In 2 weeks)
EPS estimate-$2.54

Versus estimates

Diluted EPS

Q1 2026-$1.61Beat by $1.03Q4 2025-$1.50In lineQ3 2025-$0.03Beat by $0.03Q2 2025-$0.03Beat by $0.02Q1 2025-$3.21Miss by $3.16
Q4 2024-$2.60Miss by $2.56

Ask the moment Tevogen Bio Holdings, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Tevogen Bio Holdings, Inc. report Q4 2024 earnings?
Tevogen Bio Holdings, Inc. (TVGN) reported Q4 2024 earnings on April 2, 2025.
What were Tevogen Bio Holdings, Inc.'s Q4 2024 revenue and EPS?
Tevogen Bio Holdings, Inc. reported eps of $-2.60 for Q4 2024.
Did Tevogen Bio Holdings, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.03 by $2.56.
Where can I find Tevogen Bio Holdings, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001641172-25-002426) directly on SEC EDGAR. The filing index links above go to sec.gov.